Large pharmaceutical companies say allowing Medicare to negotiate lower drug prices will stifle innovation in drug development. Read a new op-ed in Harvard Business Review to find out why that’s not so.
Timely information on people’s experiences in accessing and affording health care, and research into how public policies affect health insurance coverage and affordability nationally and at the state level.
We study health systems around the world, seek out policy and practice innovations, and compare health system performance among the U.S. and other high-income nations.
We study how this crucial program can serve its beneficiaries more equitably, effectively, and efficiently while continuing to promote improvement throughout the health care system.
We track health insurance coverage, affordability, and health outcomes for Black, Latino, Asian, Pacific Islander and Native Americans. We also highlight policies and practices needed to achieve an antiracist health system.
We use national surveys and federal data to track how well private insurance works for those who have it — including whether it enables them to get the health care they need.
